These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3596646)

  • 1. [Cushing's syndrome and adrenal gland depression caused by intranasal spray containing dexamethasone in 2 siblings].
    Varotti C; Passarini B; Pasquali R
    G Ital Dermatol Venereol; 1987 Mar; 122(3):121-3. PubMed ID: 3596646
    [No Abstract]   [Full Text] [Related]  

  • 2. Cushing syndrome secondary to abuse of dexamethasone nasal spray.
    Champion PK
    Arch Intern Med; 1974 Oct; 134(4):750-1. PubMed ID: 4412687
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cushing's syndrome induced by the use of dexamethasone administered nasally in spray form. Report of 3 cases].
    Halpern A; Hayahida CY; Pereira MA; Doi Sde Q; Lottenberg SA; Legrazie MC; Schnaider J; Carneiro CR; Bettarello A
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Feb; 36(1):18-20. PubMed ID: 7280461
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cushing's syndrome secondary to nasal instillation of dexamethasone].
    Estruch R; Tassies D; Beltrán J; Halperin EI
    Rev Clin Esp; 1991 Nov; 189(7):344-5. PubMed ID: 1767094
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cushing's syndrome secondary to nasal instillation of dexamethasone].
    Domínguez Ortega L
    Rev Clin Esp; 1992 Jul; 191(3):169. PubMed ID: 1502409
    [No Abstract]   [Full Text] [Related]  

  • 6. [Iatrogenic Cushing's syndrome caused by dexamethasome suppositories].
    Vilaseca J; Tor J; Libenson C; Guardia J
    Rev Clin Esp; 1980 Dec; 159(6):437-8. PubMed ID: 7221114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cushing's syndrome and adrenal suppression by means of intranasal use of dexamethasone preparations].
    Reiner M; Galeazzi RL; Studer H
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1836-7. PubMed ID: 929148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing's syndrome from the therapeutic use of intramuscular dexamethasone acetate.
    Hughes JM; Hichens M; Booze GW; Thorner MO
    Arch Intern Med; 1986 Sep; 146(9):1848-9. PubMed ID: 3753129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolonged fever of obscure etiology associated with Cushing's syndrome caused by self medication with dexamethasone].
    de Arruda Júnior ER
    AMB Rev Assoc Med Bras; 1986; 32(1-2):38. PubMed ID: 3491390
    [No Abstract]   [Full Text] [Related]  

  • 11. Cushing's disease: megadose dexamethasone suppression in a case refractory to medical therapy.
    Warren SE; Westbie DK; Daly R; Bower RH
    South Med J; 1979 Apr; 72(4):412-4. PubMed ID: 219547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Self-induced Cushing's syndrome due to dexamethasone abuse in nasal spray: clinical and biochemical study].
    Sastre J; Díez JJ; López Guzmán A; Iglesias P; Martínez I; Gómez-Pan A
    An Med Interna; 1994 Apr; 11(4):181-4. PubMed ID: 8043738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic Cushing's syndrome due to dexamethasone nasal drops.
    Kimmerle R; Rolla AR
    Am J Med; 1985 Oct; 79(4):535-7. PubMed ID: 4050838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cushing's syndrome due to abuse of dexamethasone nasal spray.
    Ortega LD; Grande RG
    Lancet; 1979 Jul; 2(8133):96. PubMed ID: 87988
    [No Abstract]   [Full Text] [Related]  

  • 15. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
    Cherian MP; AbdulJabbar M
    Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195
    [No Abstract]   [Full Text] [Related]  

  • 16. Iatrogenic Cushing's Syndrome Due to Intranasal Usage of Ophthalmic Dexamethasone: A Case Report.
    Orton S; Censani M
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of activity of the adrenal cortex by dexamethasone in Cushing's syndrome.
    Cassidy CE; Rosenfeld PS; Bokat MA
    J Clin Endocrinol Metab; 1966 Nov; 26(11):1181-4. PubMed ID: 5924281
    [No Abstract]   [Full Text] [Related]  

  • 18. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
    Reznik Y; Allali-Zerah V; Chayvialle JA; Leroyer R; Leymarie P; Travert G; Lebrethon MC; Budi I; Balliere AM; Mahoudeau J
    N Engl J Med; 1992 Oct; 327(14):981-6. PubMed ID: 1325609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-adrenal suppression and Cushing's syndrome after intermittent dexamethasone therapy.
    Rabhan NB
    Ann Intern Med; 1968 Dec; 69(6):1141-8. PubMed ID: 4881892
    [No Abstract]   [Full Text] [Related]  

  • 20. Iatrogenic Cushing Syndrome due to Intranasal Dexamethasone.
    Rottenstreich A; Wexler ID; Abu-Libdeh A; Berkun Y
    Clin Pediatr (Phila); 2015 Oct; 54(12):1215-7. PubMed ID: 25533884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.